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Phagocytes are crucial for host defense against bacterial pathogens. As first demonstrated by Metchnikoff,
neutrophils and mononuclear phagocytes share the capacity to engulf, kill, and digest microbial invaders.
Generally, neutrophils focus on extracellular, and mononuclear phagocytes on intracellular, pathogens.
Reciprocally, extracellular pathogens often capitalize on hindering phagocytosis and killing of phagocytes,
whereas intracellular bacteria frequently allow their engulfment and then block intracellular killing. As fore-
seen byMetchnikoff, phagocytes become highly versatile by acquiring diverse phenotypes, but still retaining
some plasticity. Further, phagocytes engage in active crosstalk with parenchymal and immune cells to pro-
mote adjunctive reactions, including inflammation, tissue healing, and remodeling. This dynamic network
allows the host to cope with different types of microbial invaders. Here we present an update of molecular
and cellular mechanisms underlying phagocyte functions in antibacterial defense. We focus on four exem-
plary bacteria ranging from an opportunistic extracellular to a persistent intracellular pathogen.. indem ich die Erscheinungen der Entzu¨ndungs-
Reaction auf die Eigenschaft der Fagocyten, dass sie
intracellula¨re Verdauung aufweisen, zuru¨ckfu¨hre, ra¨ume
ich hiermit der Lebenstha¨tigkeit der Zellen selbst den
ersten Platz ein.—Elie Metschnikoff (1884)
. by deducing from the appearance of the inflammatory
reaction to the attributes of phagocytes, namely that
they express intracellular digestion, I herewith grant the
biological activities of the cells themselves highest priority.
(freely translated from the German)
Introduction
Infectious disease is the outcome of an intense crosstalk be-
tween invading pathogen and host defense armamentarium.
This outcome is strongly influenced by the kinetics and the site
of the infection and also by the biology of the pathogen. There
are hundreds of known obligate or facultative human pathogens,
and among a given type of invader, variability is enormous.
To counteract this plethora of microbes, the immune response
is regulated by a network of positive and negative cues, with
phagocytes occupying its central hubs, rendering host defense
highly versatile.
This review focuses on phagocytes and their interactions with
bacterial pathogens. Elie Metschnikoff was the first to identify
phagocytes and to describe phagocytosis as a key antimicro-
bial process (Metschnikoff, 1884). He deduced phagocytosis as
a defense strategy from uptake of nutrients (notably particulate
food stuff) and microbial killing from nutrient digestion (Kauf-
mann, 2008). Since then, research on phagocytes has advanced
beyond phagocytosis. Phagocytes’ microbial recognition sys-
tem and functional polarization have been established (Varol
et al., 2015; Thomas and Schroder, 2013). By crosstalking with
parenchymal and various immune cells, they regulate inflam-
mation and orchestrate adaptive immunity (Varol et al., 2015;476 Immunity 44, March 15, 2016 ª2016 Elsevier Inc.Jaillon et al., 2013; Kruger et al., 2015). We will highlight diver-
sity and multitasking of phagocytes during bacterial infections,
discuss how pathogens hijack phagocyte-specific defense
mechanisms, and review roles of phagocytes in inflammation
and pathology.Professional Phagocytes and Microbes
As pointed out by Metschnikoff (1884), professional phago-
cytes include neutrophils (called microphages by Metschnikoff),
short-lived aggressive phagocytes, and mononuclear phago-
cytes (called macrophages by Metschnikoff). The latter are
long-lived phagocytes, which undergo differentiation in
response to exogenous and endogenous stimuli (Kaufmann,
2008). Sensing bacteria through pattern recognition receptors
(PRRs) enables phagocytes to categorize microbial invaders
and to initiate appropriate signaling cascades that mobilize de-
fense mechanisms in the phagocytes themselves, and also alert
other immune cells (Plu¨ddemann et al., 2011; Thomas and
Schroder, 2013). For certain pathogens, phagocytes are self-
sustaining, i.e., sterile eradication is achieved by intrinsic effector
mechanisms. For others, phagocytes need the support of addi-
tional immune cells, notably parenchymal cells that secrete anti-
microbial peptides, chemokines, and cytokines to stimulate
phagocyte chemotaxis and bacterial killing, antibody-producing
B cells to improve phagocytosis, and T or NK cells to activate
antimicrobial activities. The most enduring pathogens can even
survive in activated phagocytes requiring adjunctive tissue reac-
tions, such as granulomas or abscesses, for their containment
(Thammavongsa et al., 2015; Dorhoi and Kaufmann, 2015).
The genesis of defense occurs at three layers (Figure 1). (1) At
the intracellular layer, signaling pathways within phagocytes
directly activate defense mechanisms, e.g., through reactive
oxygen and nitrogen intermediates (ROIs and RNIs, respec-
tively) or cell-autonomous resistance. (2) At the intercellular
layer, communication signals, notably cytokines, alert additional
Figure 1. Multilayered Host Defense against Bacterial Infection
Intracellular layer: upon tissue invasion, and in the absence of pathogen evasion strategies, bacteria are sensed, engulfed by, and destroyed in phagocytes.
Intercellular layer: at the site of infection, complex cellular networking takes place. Phagocytes bi-directionally interact with endothelial cells, stroma cells,
lymphocytes, and dendritic cells. Organ layer: if bacteria are not successfully eliminated by phagocytes, profound tissue alterations emerge, including formation
of granulomas or abscesses or persistence of bacteria in biofilms, thereby changing organ architecture and functionality. Not shown in figure are tissue-re-
modeling events to reestablish homeostasis after bacterial elimination. Abbreviations are as follows: Ab, antibody; B, B cell; CR, complement receptor; DC,
dendritic cell; FcR, Fc receptor; IFN-g, interferon gamma; IL, interleukin; MF, macrophage; NK, natural killer cell; PMN, polymorphonuclear neutrophil; PRR,
pattern recognition receptor; T, T cell; Th1, type 1 T helper cell; TNF-a, tumor necrosis factor alpha; Treg, regulatory T cell; TSLP, thymic stromal lymphopoietin.
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Revieweffectors and instruct acquired immunity tomobilizemost appro-
priate defense mechanisms. Recruitment of leukocytes to the
site of microbial invasion results in inflammation, generally
improving bacterial control but damaging tissues. (3) At the or-
gan layer, pathogen disposal is followed by resolution of inflam-
mation and tissue repair in a process orchestrated by phago-
cytes. Inability to eliminate bacteria results in non-resolving
inflammation, tissue damage, and remodeling, which is best
exemplified by granulomas and abscesses in tuberculosis and
staphylococcal infections, respectively. Cell-cell interactions
within inflammatory foci control containment and eventually
elimination of pathogens. Hence, subsequent to pathogendefeat, mechanisms become active to reestablish physiological
organ function and to decelerate the immune response and
avoid chronic inflammation.
Bacterial Pathogens
Relative importance of macrophages and neutrophils for de-
fense against bacteria largely depends on pathogen biology.
Opportunistic bacteria, which cannot establish stable infection
in immunocompetent individuals, can do so if the immune sys-
tem is weakened. One example is Pseudomonas aeruginosa,
which is readily killed by competent neutrophils but can cause
local or generalized disease if bacterial clearance is impairedImmunity 44, March 15, 2016 ª2016 Elsevier Inc. 477
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Review(Table 1; Andrews and Sullivan, 2003). Most prominent are
chronic lung infections in patients with cystic fibrosis (CF) or
chronic obstructive pulmonary disease (COPD). Other bacteria
can, but do not necessarily, cause disease in immunocompetent
individuals. Staphylococcus aureus colonizes a large proportion
of the human population permanently (Table 1; Thammavongsa
et al., 2015). Under certain circumstances, colonization can turn
into stable infection leading to diseases of the skin and soft tis-
sue. In such cases, S. aureus typically causes acute disease
with neutrophils playing a major role in bacterial control. Antibi-
otic-resistant strains (e.g., methicillin-resistant S. aureus,
MRSA) are implicated in community-acquired pneumonia and
represent major nosocomial agents. Generally speaking, both
P. aeruginosa and S. aureus are extracellular bacteria that are
eventually killed by professional phagocytes. Accordingly, as a
major evasion strategy, extracellular bacteria circumvent phago-
cytosis via multiple mechanisms, e.g., by preventing uptake by,
or by killing of, phagocytes. Nevertheless, they can persist in
shielded niches.
Intracellular bacteria survive within professional phagocytes.
Their preferred targets are macrophages with their long survival
rate, which, at least in the resting state, are less aggressive.
Listeria monocytogenes can survive in resting macrophages
but is readily killed by macrophages activated by interferon
gamma (IFN-g) (Table 1). Mycobacterium tuberculosis persists
not only in resting, but also in activated, macrophages (Table 1).
Persistent bacteria acquire a dormant stage, with replication and
metabolism coming to a standstill (Gengenbacher and Kauf-
mann, 2012). Persistence of dormant M. tuberculosis needs
continuous macrophage activation, which operates at full effi-
ciency only in the context of a special tissue reaction, the gran-
uloma (Dorhoi and Kaufmann, 2015). Here, disease outbreak
can be prevented but sterile bacterial eradication is only rarely
achieved.
Macrophages and Monocytes
Macrophages populate and scrutinize all tissues for signals
perturbing homeostasis whereas monocytes screen the blood
for intruders and readily access foci of infection (Varol et al.,
2015). The kind of mononuclear subset interacting with bac-
teria varies during infection (from initial colonization to stable
infection) and type of disease (acute versus chronic; localized
versus systemic).
Macrophages express reduced motility and heightened
phagocytic activities, emphasizing their primary goal to safe-
guard ‘‘their’’ tissue against infectious insult. Upon sensing of
bacteria or alarmins, macrophages activate autocrine feed-
forward (e.g., tumor necrosis factor-alpha and interleukin-1
[TNF-a and IL-1]) and feedback loops (e.g., IL-10) as well as
paracrine networks to instruct acquired immunity (e.g., IL-12)
and attract blood phagocytes (CC and CXC chemokines)
(Figure 1). Pathogen elimination triggers resolution of inflamma-
tion, and macrophages repair damaged tissue through efferocy-
tosis, pro-resolving lipid mediators, and profibrotic and proan-
giogenic programs. Each macrophage population expresses
tissue-specific transcriptional programs that are epigenetically
conditioned (Lavin et al., 2014). Bacterial pathogens manipulate
unique transcription factors associated with tissue identity of
distinct macrophage populations. For instance, M. tuberculosis478 Immunity 44, March 15, 2016 ª2016 Elsevier Inc.upregulates peroxisome proliferator-activated receptor gamma
(PPAR-g) in human macrophages (Rajaram et al., 2010), which
instructs development of alveolar macrophages (Schneider
et al., 2014). As guardians of tissue homeostasis, macrophages
express complex surveillance systems, involving PRRs, nuclear
receptors, cytokine receptors, and adhesion molecules, which
vary between tissues (Plu¨ddemann et al., 2011). These observa-
tions bear relevance for infection biology, given the organ
tropism of bacteria. For example, M. tuberculosis primarily af-
fects the lung. The mannose receptor (MR) is highly expressed
on alveolar macrophages, binds bacterial mannosylated surface
structures (Schlesinger, 1996), and contributes to development
of pulmonary tuberculosis. Such mucosal sites, including the
lung and the gut, are continuously exposed to microbes. To
avoid overt inflammation, homeostatic deactivation programs,
including signaling via interleukin-10 (IL-10), transforming growth
factor-beta (TGF-b), and CD200, are active in tissue macro-
phages (Varol et al., 2015). These homeostatic pathways are
misused during infection. M. tuberculosis replicates unrestrict-
edly within alveolar macrophages (Repasy et al., 2013). Myco-
bacterial glycolipids, as well as mycobacterial-induced IFN-I,
are potent IL-10 inducers that facilitate bacterial growth (Dorhoi
and Kaufmann, 2014). Endogenous IL-10 blocks phagosomal
maturation, which is partially dependent on the signal transducer
and activation of transcription 3 (STAT-3). Depletion of alveolar
macrophages restricts replication of M. tuberculosis within the
lung (Leemans et al., 2001), indicating that it exploits pulmonary
macrophages for its growth.
Monocytes constitute a highly dynamic and versatile cell
population complementing tissue macrophages on demand.
They encompass two distinct subsets, in humans differentially
expressing CD14 and CD16. In the mouse, Ly6CloCX3CR1hi
CCR2–CD62L–CD43hi monocytes survey endothelial cells,
whereas the Ly6ChiCX3CR1intCCR2+CD62L+CD43lo monocytes
are readily recruited to the site of infection. The critical role of
CCR2 chemokine receptor-expressing monocytes in antibacte-
rial defense is well established (Samstein et al., 2013; Serbina
and Pamer, 2006). Yet, CCR2+ monocytes can also serve as
permissive niche for tubercle bacilli (Antonelli et al., 2010).
Generally, Ly6Chi monocytes have a short half-life and their
developmental continuum keeps them versatile. Once recruited
to tissue sites, monocytes can differentiate into macrophages
and dendritic cells or can persist at sites of injury and perform
antibacterial or tissue repair functions. Monocytes can also
contribute to angiogenesis with relevance for antibacterial de-
fense. Monocyte-derivedmacrophages promote vascularization
of granulomas, thus supporting replication and dissemination
of mycobacteria (Oehlers et al., 2015). Propensity of monocytes
to exert various functions drives their predominant beneficial
(activation of T cell responses [Samstein et al., 2013]) or detri-
mental (support of bacillary replication) role at a given stage of
the disease.
Coexistence and cross-regulation of embryonic-derived tis-
sue macrophages and monocytes during infection is just being
elucidated. During urinary tract infection, resident macrophages
cooperate with recruited Ly6C+ monocytes to attract bacteri-
cidal neutrophils (Schiwon et al., 2014). In experimental listeri-
osis (Ble´riot et al., 2015), inflammatory monocytes become
CXCR2loCX3CR1hi reparatory cells. Listeriae induce release of
Table 1. Selection of Major Bacterial Pathogens and Diseases They Cause
Pseudomonas aeruginosa Staphylococcus aureus Listeria monocytogenes Mycobacterium tuberculosis
Classification 1 of 65 species; gram-negative
rod; motile, nonspore-forming,
facultative anaerobic
1 of 50 species; gram-positive coccus;
nonmotile, nonspore-forming, facultative
anaerobic
1 of 10 species; gram-positive rod; motile,
nonspore-forming, facultative anaerobic
organism, low temperature-resistant
1 of >50 species; weakly gram-positive
acid-fast rod; nonmotile, nonspore-
forming, aerobic to microaerophilic,
dysgonic growth
Preferred habitat ubiquitous in soil and water skin and mucosa ubiquitous in the environment lung
Preferred host opportunistic pathogen of
plants, nematodes, insects,
mammals and others
human; domestic animals wide host spectrum, including mammals





low carriage in nonhospitalized
individuals, profound increase
after hospitalization
>20% persistent carriers (healthy adults),
60% intermittent carriers
rare latent infection in 2 billion individuals of
whom fewer than 10% develop active
tuberculosis during their lifetime
Transmission contact with contaminated
material; human to human
smear infection contaminated food aerogenic
Pathogenicity evasion of phagocytosis
due to exopolysaccharides;
biofilm formation
purulent infections due to massive
leukocyte death; abscesses as protective
niche; sepsis: bacteraemia and cytokine
storm; intoxications
intracellular pathogen in resting
macrophages susceptible to activated
macrophages; perforation of phagosomal
membranes allows egress into cytosol;
intracellular movement and cell-to-cell
spread avoids contact with extracellular
milieu
pathogenicity often caused by immune
response; granulomas contain bacteria and
harm host; solid granulomas contain
bacteria; necrotic or caseous granulomas






susceptible to neutrophil killing;
sometimes persists within macrophages;
superantigen activity: polyclonal T cell
activation and cytokine storm
macrophages serve as habitat and
effector; protection strictly T cell-
dependent
paragon intracellular bacterium, mostly
persisting in resting macrophages, can
persist in few other cells; activated
macrophages inhibit mycobacterial growth,





phenazine pigments, which are
redox-active
many toxins, virulence factors, enzymes,
including: a, b, g, and d hemolysins
(cytolytic for leukocytes including
phagocytes); staphylokinase (fibrinolytic
activity cleaves fibrotic capsules);
adenosine, proteases, and nucleases
(immune suppression and evasion);
enterotoxins produced in contaminated
food: diarrhea and vomiting; toxic shock
syndrome toxin (toxic shock syndrome)
listeriolysin, a cholesterol-dependent
cytolysin, perforates phagosomal
membrane; actin A polymerizes host
cell actin, thereby allowing intracellular
movement and cell-to-cell spreading
numerous proteins and (glyco)lipids act as
virulence factors or promote persistence/
growth in host; many virulence and
persistence genes encoded in regions of
difference (RD), notably ESX system in RD1
Clinical
syndromes
chronic pneumonia in >80% adult
cystic fibrosis patients; local and
generalized nosocomial infections
(10% of hospital infections): local:
prosthetics, obstruction, wounds;
generalized: sepsis in burn
patients
pus-forming skin infections; infections of
inner organs leading to abscesses; major
(30%) cause of sepsis/bacteremia; major
gram-positive cause of nosocomial
infections, frequently associated with
prosthetic material; intoxications (food
poisoning, toxic shock syndrome)
pathogenic for immune-compromised
individuals including elderly, pregnant
women; primarily meningitis,
encephalitis, bacteremia, and sepsis;
infection during pregnancy results in
abortion, miscarriage, and stillbirth
80% pulmonary tuberculosis; 20%
extrapulmonary tuberculosis; miliary
tuberculosis: disseminated disease in
immunocompromised patients and infants
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ReviewIL-33 by necroptotic Kupffer cells, which stimulates IL-4 produc-
tion in basophils, thereby facilitating conversion of monocytes
into reparatory macrophages (Ble´riot et al., 2015). Similar to
type 2 pathologies characterized by massive proliferation of tis-
sue macrophages (Varol et al., 2015), Ly6Chi monocyte-derived
macrophages proliferate and replenish the pool of Kupffer cells
in listeriosis (Ble´riot et al., 2015). These studies unveil intensive
crosstalk between phagocyte subsets during bacterial insult
and emphasize the functional plasticity of mononuclear phago-
cytes. Accordingly, the binary classification of polarized macro-
phages into two distinct phenotypes, M1 (classically activated
by Th1 cytokines) and M2 (alternatively activated by Th2 or
Treg cells), relevant for antibacterial defense and tissue repair,
respectively, has been amended recently (Xue et al., 2014).
The polarization process, which is reversible per se, is induced
by various microbial (PRR agonists) and host (cytokines, lipids)
stimuli and results in a spectrum of macrophage phenotypes
rather than a few distinct subsets. This continuum furnishes
macrophages with the best possible means for combating
different pathogens albeit with various proficiencies.
Neutrophils
Neutrophils have a short half-life, unless activated by inflamma-
tory stimuli or growth factors at sites of infection (Kruger et al.,
2015), and possess numerous antimicrobial effector mecha-
nisms, which they canmobilize rapidly (Nauseef and Borregaard,
2014). Neutrophils are essential for defense against extracellular
bacteria (Andrews and Sullivan, 2003), but their bactericidal
molecules are equally detrimental for the host if uncontrolled
(Kruger et al., 2015; Dorhoi and Kaufmann, 2015). The relevance
of neutrophils for diseases caused by intracellular bacteria is
variable. Depletion of neutrophils can render mice susceptible
to L. monocytogenes (Carr et al., 2011; Shi et al., 2011). On the
contrary, in mice highly susceptible to tuberculosis, depletion
of neutrophils protects against lethality (Dorhoi et al., 2014;
Yeremeev et al., 2015).
Upon sensing of invading bacteria, tissue-resident macro-
phages alert neutrophils by activating vascular endothelium
through cytokines (TNF, IL-1) thus fostering rolling and adhe-
sion and direct neutrophil migration via chemokines. At the
infection foci, neutrophils phagocytose bacteria, primarily upon
opsonization by complement and antibodies (Jaillon et al.,
2013). Depending on particle size (Branzk et al., 2014), neutro-
phils can directly extrude neutrophil extracellular traps (NETs),
with potent antimicrobial activity (Brinkmann et al., 2004). Neu-
trophils modulate leukocyte recruitment by release of pre-stored
(e.g., CXCL8) or de novo-produced chemokines and cytokines.
Intrinsic regulation of chemotaxis has been reported in tubercu-
losis (Dorhoi et al., 2013). Once present in tissue, neutrophils first
engulf and then kill bacteria, after which they undergo cell death.
Recently, activities beyond clearance of bacterial pathogens
have emerged. Neutrophils orchestrate adaptive immunity and
contribute to the resolution of inflammation (Jaillon et al., 2013;
Kruger et al., 2015). Even though neutrophils can directly present
antigens of certain pathogens, including mycobacteria (Abadie
et al., 2005), they primarily cooperate with dendritic cells for
T cell activation in tuberculosis (Blomgran and Ernst, 2011).
Once bacteria have been cleared, neutrophils contribute to the
resolution of inflammation. First, apoptotic neutrophils induce
Figure 2. Antibacterial Defense
Mechanisms in Phagocytes
Principally, bacteria are destroyed in phag-
olysosomes generated by fusion of phagosomes
with lysosomes, within phagosomes fused with
granules, or in autophagolysosomes. Bacterial
killing within phagolysosomes is mediated by
distinct enzymes, which generate toxic radicals, at
the vacuolar membrane. In addition, transport sys-
tems allow phagosomal traffic of cations to limit
bacterial replication. Phagocytes also degranulate
and form extracellular traps to destroy extracellular
bacteria. Mechanisms operating in both macro-
phages and neutrophils are depicted independent
of predominant occurrence in humans or experi-
mental species. Abbreviations are as follows:
Ab, antibody; AMPs, antimicrobial peptides; Arg,
L arginine; ETs, extracellular traps; IDO, indole-
amine 2,3-dioxygenase; Fe, iron; Mn, manganese;
GBPs, guanylate-binding proteins; HOCI, hypo-
chlorousacid; iNOS, inducible nitric oxide synthase;
MPO, myeloperoxidase; NADPH, nicotinamide
adenine dinucleotide phosphate-oxidase; NO, nitric
oxide; O2, oxygen; Zn, zinc; Cu, copper.
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Reviewtissue repair programs in macrophages through detection of
‘‘eat me’’ signals that promote an IL-10 regulatory phenotype.
Second, neutrophils shift from leukotriene B4 (LTB4) to lipoxin
A4 (LXA4) production upon sensing first-phase eicosanoids
such as PGE2, and produce resolvins as well as annexin 1 (Jail-
lon et al., 2013).
Phenotypic diversity of neutrophils during bacterial infection is
increasingly appreciated. During infection with S. aureus, three
subtypes of neutrophils have been described based on pheno-
typic markers (CD11b, CD49), expression of PRRs (TLR-2,
TLR-4, TLR-5, TLR-8, TLR-9), and capacity to release immune
mediators that activate macrophages (induction of M1 through
IL-12 and CCL3 and M2 through IL-10 and CCL2, respectively)
(Tsuda et al., 2004). In addition, neutrophils with suppressive
activity toward T cells, namely granulocytic myeloid-derived
suppressor cells, have been identified in tuberculosis (du Plessis
et al., 2013; Knaul et al., 2014) and staphylococcal infections
(Heim et al., 2014; Skabytska et al., 2014). Such cells are poten-
tial disease biomarkers (El Daker et al., 2015) because they
promote lung injury in tuberculosis. During staphylococcal infec-
tion, suppressive granulocytes facilitate persistence of bacteria
(Heim et al., 2015) and are main determinants for immunosup-
pression (Tebartz et al., 2015).
Phagocytosis
The mechanisms of pathogen internalization vary with both
phagocyte and bacterial type. Pathogen killing relies on shared
and unique mechanisms operative in macrophages and neu-
trophils (Figure 2). During coevolution, bacterial pathogens
have developed diverse modalities to interfere with this broad
arsenal of phagocytes and invade or persist within the host
(Figure 3).Immunity 4Phagocytes employ PRRs and recep-
tors for Ig (FcRs) and complement (CRs)
for phagocytosis. Whereas intracellular
bacteria often target phagocytic recep-
tors for entry into host cells, extracellularbacteria frequently employ antiphagocytic mechanisms. Several
extracellular bacteria, including S. aureus and P. aeruginosa,
evade phagocytosis by switching from planktonic growth to bio-
film formation (Thammavongsa et al., 2015). Moreover, S. aureus
in biofilm promotes differentiation of macrophages toward an
M2-like phenotype by attenuating iNOS and augmenting Arg1
expression, thereby reducing their bactericidal capacity (Thur-
low et al., 2011). Mobility of P. aeruginosa afforded by flagella fa-
cilitates initial colonization. Once colonization is established, bio-
film formation and loss of flagella are induced by neutrophil
elastase-induced stress (Lovewell et al., 2014).
During persistent infection in an immunocompromised
host, P. aeruginosa changes its morphology. Bacteria begin to
express mucoid exopolysaccharides, which protect against
complement-dependent phagocytosis, and alginate, which
shields them from macrophage killing (Leid et al., 2005). Strain-
dependent interference with phagocytosis has been observed:
P. aeruginosa strain producing ExoT and ExoS with GTPase
activity hinders the phagocytic capacity of immune cells (Love-
well et al., 2014).
S. aureus has developed an enormous variety of strategies
that interfere with opsonization. Bacteria develop a microcap-
sule to restrict their engulfment. Staphylococcal proteins bind
to the Fc region of IgG, thereby inhibiting FcR-dependent phago-
cytosis (Kim et al., 2012). The staphylococcal superantigen-like
protein 7 (SSL7) binds IgA and restrains opsonization at mucosal
sites (Thammavongsa et al., 2015). Complement-dependent
phagocytosis is altered by the immune modulator staphylo-
coccal complement inhibitor (chemotaxis inhibitory protein
[SCIN]) and by SSL7, which inhibits the complement component
C5a. Inactivation of the complement fragment C3 has been re-
ported for several virulence factors of S. aureus (Thammavongsa4, March 15, 2016 ª2016 Elsevier Inc. 481
Figure 3. Bacterial Evasion Strategies in
Phagocytes
(A) Macrophages employ distinct key adaptor
molecules (MyD88, CARD9, TRIF) and cytosolic
sensors (AIM2, NLRP3, NAIP, STING, cGAS) to
release inflammatory mediators upon infection.
M. tuberculosis avoids killing in macrophages by
restricting phagosome maturation and autophagy,
by detoxifying toxic radicals, and by egressing into
the cytosol. L. monocytogenes escapes into the
cytosol where it induces actin polymerization
to actively infect adjacent cells. S. aureus, like
P. aeruginosa, hinders phagocytosis, nullifies toxic
radicals and antimicrobial peptides, and trans-
locates into the cytosol.
(B) Neutrophils produce inflammatory mediators
and frequently undergo necrosis after infection.
L. monocytogenes and P. aeruginosa are killed in
phagosomes or NETs, whereas M. tuberculosis
and S. aureus can detoxify reactive oxygen spe-
cies, resist NET killing, and hinder phagocytosis.
Abbreviations are as follows: ActA, actin assembly
inducing protein; AIM2, absent in melanoma 2;
AMPs, antimicrobial peptides; CARD9, caspase
recruitment domain-containing protein 9; cGAS,
cyclic GMP-AMP synthase; CLR, C-type lectin
receptors; CR, complement receptor; ESX-1, early
secretory antigen target 6 system 1, part of the
type VII secretion system; ETs, extracellular traps;
FcR, Fc receptor; Hly, listeriolysin; Mtb, Myco-
bacterium tuberculosis; MyD88, myeloid differen-
tiation primary response gene 88; NETs, neutrophil
extracellular traps; NLRP3, NLR family, pyrin
domain-containing 3; ROI, reactive oxygen in-
termediates; RNI, reactive nitrogen intermediates;
STING, stimulator of interferon genes; TRIF, TIR-
domain-containing adaptor-inducing interferon-b.
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Reviewet al., 2015). The staphylococcal protease staphylokinase
cleaves plasminogen to plasmin that covers the bacterial sur-
face, thereby hindering activation of humoral host factors (Ko
et al., 2013).
Complement receptors (CRs) and particularly nonopsonic
receptors ensure a safe entry of M. tuberculosis into macro-
phages, which activates the alternative and classical pathway
for complement activation (Schlesinger, 1996). In addition, C-
type lectin receptors (CLRs) (Wilson et al., 2015; Schlesinger,
1996) and the scavenger receptor (SR) CD36 (Philips et al.,
2005) contribute to engulfment. Autophagy restricts degredation
of the transcription factor NFE2L2 through SQTM1 or p62, which
in turn affects expression of additional SRs, namely MARCO and482 Immunity 44, March 15, 2016 ª2016 Elsevier Inc.MSR1, on macrophages to orchestrate
phagocytosis of M. tuberculosis (Bonilla
et al., 2013). Potent stimulators of antimy-
cobacterial responses in macrophages,
such as IFN-g, induce a switch from re-
ceptor-mediated phagocytosis to macro-
pinocytosis (Bosedasgupta and Pieters,
2014). Macropinocytosis bypasses arrest
of phagosome-lysosome fusion thereby
facilitating killing of M. tuberculosis.
Similar effects have been reported for up-
take of Ig-opsonized bacilli (Schlesinger,
1996). Parenchymal cells modulate
phagocytosis of M. tuberculosis: surfac-tant protein A (SP-A) upregulates MRs to promote bacterial
engulfment and SP-D impedes this process by masking myco-
bacterial mannosylated lipoarabinomannan (Man-LAM) to block
MR-dependent uptake (Scordo et al., 2015).
Phagosome Maturation and Evasion
Phagocytosis initiates a series of fusion and fission events
involving compartments of the endocytic pathway that ultimately
result in a phagolysosome. Several intracellular bacteria interfere
with phagosome maturation to facilitate their survival (Figure 3).
M. tuberculosis replicates in the early endosomal compartment.
Mycobacterial sulfatides and cell wall glycolipids, such as
ManLAM, thwart phagolysosome fusion. Phagocytosis via the
Immunity
ReviewMR (Kang et al., 2005) and CR (Schlesinger, 1996) restrains
fusion of theM. tuberculosis phagosome with lysosomes. More-
over, mycobacterial lipid phosphatase SapM, tyrosine phos-
phatase PtpA, and protein kinase G (PknG) impede phagosome
maturation (Lugo-Villarino and Neyrolles, 2014). Recently,
manipulation of phagosome acidification has been reported for
S. aureus in ex vivo macrophage cultures and using large inocula
(Sokolovska et al., 2013; Jubrail et al., 2016), which buffer phag-
osomal pH concurrent with host-produced ROIs. Other studies
based on live cell microscopy argue that staphylococci do not
affect phagolysosome fusion. Rather, they withstand killing,
replicate in mature phagosomes, and induce macrophage death
followed by bacterial dissemination (Flannagan et al., 2015),
possibly relying on bacterial systems for detoxification of
toxic host compounds within the phagolysosome. In either
case, persistence of S. aureus in macrophages, despite being
perceived as extracellular bacterium, has been described
repeatedly (Kubica et al., 2008).
Evasion from the phagosome into the cytosol transiently
benefits the pathogen, although cytosolic presence alerts
cytosolic surveillance pathways and induces inflammatorymedi-
ators as well as autophagy (Figure 3). Cytosolic invasion has
been extensively studied for L. monocytogenes and more
recently described for M. tuberculosis and S. aureus.
L. monocytogenes employs listeriolysin (Hly), a thiol-activated
cholesterol-dependent cytolysin for egression into the cytosol.
Hly is activated by a host thiol reductase (Singh et al., 2008)
and is degraded once bacteria have entered the cytosol
(Schnupf et al., 2007), thus restricting death of host cells. Subse-
quently, L. monocytogenes induces tails of actin filaments by
means of ActA that facilitate its propulsion toward the outer re-
gion and formation of pseudopods (Williams et al., 2012). The
L. monocytogenes-containing pseudopods are internalized by
adjacent cells, enabling L. monocytogenes to infect numerous
cells and avoid exposure to extracellular defense mechanisms.
M. tuberculosis employs proteins encoded by the type 7
secretion system (T7SS), located in the gene region of differenti-
ation 1 (RD1), to egress into the cytosol (van der Wel et al.,
2007). By disturbing the integrity of the phagosomal membrane,
phagocyte viability is impaired and inflammation induced in
the lung (Simeone et al., 2015). Cytosolic translocation of
M. tuberculosis is conditioned by its propensity to restrict
acidification of the phagosome (Simeone et al., 2015). Virulent
mycobacteria limit phagosomal acidification by interfering with
the endosomal maturation pathway, i.e., excluding host vacu-
olar-H+-ATPase from the phagosomal membrane. Cytosolic
replication after phagosomal escape has also been reported
for S. aureus, and phenol-soluble modulin alpha (PSMa) and
the agr-controlled pore-forming a-toxin have been implicated
(Thammavongsa et al., 2015).
Oxidative and Nitrosative Defense
Phagocytes utilize highly reactive toxic molecules, particularly
ROIs and RNIs, for microbial killing (Figure 2). Synthesis of ROI
is mediated by the membrane-bound nicotinamide adenine
dinucleotide phosphate-oxidase (NADPH oxidase) complex. Its
assembly is initiated in phagocytes by PRRs, FcRs, and IFN-g
receptor (Mosser and Edwards, 2008). Short-lived radicals
including singlet oxygen (1O2) and hydroxyl (
dOH) radicals arepowerful oxidants causing damage to DNA, membrane lipids,
and proteins. ROIs are also produced by mitochondria in
response to TLR agonists. Juxtaposition of mitochondria with
the bacterial phagosome for ROI release is mediated by kinases
Mst1 and Mst2 (Geng et al., 2015). Neutrophils, monocytes, and
certain tissue macrophages (e.g., Kupffer cells) can further
process ROIs by means of myeloperoxidase (MPO) to generate
hypochlorous acid (HOCl) and chloramines. During infection with
S. aureus, most of the neutrophil chloride reservoir is mobilized
to the phagosomes and the extracellular space involving trans-
porters, including the CF transmembrane conductance regulator
(CFTR) in mature neutrophils (Nauseef and Borregaard, 2014).
Nitric oxide (NO) is synthesized from L-arginine by the induc-
ible NO synthase (iNOS) and further transformed into peroxyni-
trate and nitrosothiols upon reaction with ROIs. RNIs inactivate
iron (Fe)- and sulfur (S)-containing enzymes, S-nitrosylate pro-
teins, oxidate lipids, and damage DNA. Phagocytes activate
iNOS after stimulation with PRR agonists, IFN-g, and proinflam-
matory cytokines (Mosser and Edwards, 2008). Nonconventional
activators, such as the alarmin IL-33, have been implicated in
iNOS-dependent killing of S. aureus in macrophages (Li et al.,
2014). NO also stimulates Nrf2 expression in macrophages,
thereby upregulating ferroportin (FPN) and boosting nutritional
immunity in macrophages (Nairz et al., 2013).
Most bacterial species are susceptible to ROI killing under
axenic conditions. Consistently, humans deficient in ROIs,
e.g., chronic granulomatous disease patients, are highly sus-
ceptible to extracellular bacteria, such as S. aureus (Thamma-
vongsa et al., 2015), and at risk of intracellular ones, including
M. tuberculosis (Lee et al., 2008). ROIs and particularly CFTR
mediate phagosomal HOCl production (Ng et al., 2014) and
killing of P. aeruginosa (Del Porto et al., 2011; Nauseef and Bor-
regaard, 2014). Although NADPH-deficient mice are resistant
against tuberculosis, a role for macrophage-derived ROIs in hu-
man tuberculosis has been reported (Bustamante et al., 2011).
NADPH-deficient animals are relatively vulnerable to infection
with KatG mutant bacilli, thus suggesting that either abundance
of ROI varies in mice and humans or that bacterial mechanisms
responsible for ROI detoxification are differentially effective
in various species. In contrast to ROIs, RNIs play a central role
in mycobacterial killing by mouse macrophages (Flesch and
Kaufmann, 1991). Although the capacity of human phagocytes
to synthesize RNIs in sufficient abundance remains controver-
sial, iNOS has been identified in macrophages of patients and
nonhuman primates with tuberculosis (Mattila et al., 2013; Nich-
olson et al., 1996).
Microbes employ numerous evasion strategies from ROI and
RNI killing (Figure3).Pathogenbinding tomacrophage-expressed
CR1 and CR3 overcomes ROI production, thereby providing safe
access to the intracellular habitat for M. tuberculosis. Inside
activated phagocytes, microbial scavenger molecules, such as
mycothiols and phthiocol fromM. tuberculosis (Ehrt and Schnap-
pinger, 2009), contribute to resistance against oxidative and
nitrosative stress. M. tuberculosis as well as S. aureus produce
superoxide dismutase and catalases to nullify ROIs and RNIs, at
least in part (Ehrt and Schnappinger, 2009; Thammavongsa
et al., 2015). S. aureus has developed additional mechanisms to
overcome oxidative killing in phagocytes: release of adenosine
(Thammavongsa et al., 2009) and the carotenoid antioxidantImmunity 44, March 15, 2016 ª2016 Elsevier Inc. 483
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of CD353 to restrain NOX2 activity (Wang et al., 2012); and lactate
and flavohemoglobin to detoxify RNIs (Richardson et al., 2008).
Metabolic Privation and Intoxication
Metabolic privation refers to sequestration of crucial nutrients,
e.g., the amino acid tryptophan (Trp), or cations, which act as
cofactors for enzymes in key biological processes. Intoxication
involves active mobilization of ‘‘death metals’’ (Neyrolles et al.,
2015) toward microbial niches best characterized for copper
(Cu) and zinc (Zn) (Figure 2).
Few microbes are naturally auxotrophic for Trp (Chlamydiae
and Leishmaniae). Yet under host pressure, e.g., within activated
macrophages, microbes upregulate their metabolic pathways
for specific amino acids such as Trp. As a consequence, auxo-
trophic M. tuberculosis mutants for Trp are attenuated (Zhang
et al., 2013). During steady state, macrophages harbor large
amounts of Trp, which support the growth of intracellular tuber-
cle bacilli. IFN-g induces indoleamine 2,3-dioxygenase (IDO)
in phagocytes, resulting in consumption of the intracellular Trp
pool. This metabolic switch requires activation of bacterial Trp
biosynthesis for survival (Zhang et al., 2013).
Both microbes and host require Fe. Bacteria have developed
strategies to interfere with Fe homeostasis and the mammalian
host generally deprives the pathogen of Fe (Schaible and Kauf-
mann, 2004). A particular mechanism can be advantageous or
detrimental, according to the habitat and other features of the
pathogen. Principally, systemic Fe withdrawal and hypoferremia
favor the host over extracellular bacteria, and restriction of Fe
uptake by phagocytes and intensified export contribute to con-
trol of intracellular pathogens (Neyrolles et al., 2015). Phagocytes
employ unique molecules to control Fe homeostasis. Several
proteins including transferrin, lactoferrin, haptoglobin, hemo-
pexin, and lipocalin-1 and -2 bind Fe in the extracellular space.
Phagocytes acquire transferrin-Fe complexes from the extracel-
lular milieu through the transferrin receptor (TfR) in early endo-
somes. In addition, macrophages can incorporate Fe via the
divalent metal transporter-1 (DMT1). The Nramp system further
transports Fe from acidified phagosomes to the cytosol, where
it binds ferritin. FPN mediates Fe export and FPN abundance
is in turn controlled by hepcidin. Thus, multiple tightly linked sys-
tems govern intracellular Fe availability. Pathogens can interfere
with this complex regulatory process at various steps. Both
M. tuberculosis and S. aureus possess Fe-binding proteins,
such as chelators (siderophores), transferrin-binding proteins,
heme-like proteins, and ABC transporters. Mycobactins acquire
intracellular Fe and staphyloferrins lyse erythrocytes to access
Fe from hemoglobin (Hammer and Skaar, 2011). A heme acqui-
sition system has also been reported for M. tuberculosis (Tullius
et al., 2011). Bacterial siderophores can be counterregulated by
lipocalins produced by phagocytes and epithelial cells (Johnson
et al., 2010). IFN-g-activated phagocytes limit intracellular
Fe availability by downregulating TfR and ferritin. IFN-g also in-
duces Nramp1, which has been associated with protection
against tuberculosis (Malik et al., 2005). Neutrophilis are rich in
calprotectin, which binds manganese (Mn) and Zn and plays a
major role in defense against extracellular bacteria. This protein
chelates metals within abscesses harboring S. aureus, thereby
restricting its growth (Kehl-Fie et al., 2011). Tuberculous granu-484 Immunity 44, March 15, 2016 ª2016 Elsevier Inc.lomas are rich in calprotectin (Gopal et al., 2013), which is rather
detrimental in tuberculosis.
To defend persistent intracellular bacteria, macrophages
accumulate bacterial toxic metal ions Zn and Cu within their
phagosomes. M. tuberculosis exploits metal efflux and detoxifi-
cation to resist such intoxication by the host cell. Upregulation of
P-type ATPases, transporters, and oxidases facilitate bacillary
persistence under metal intoxications in macrophages (Neyr-
olles et al., 2015). Generally, metallobiology of phagocytes dur-
ing bacterial infections awaits further investigations.
GTPase-Controlled Vacuolar Events
Phagocytes stimulated by IFN I and II upregulate several small
GTPase members involved in host defense and inflammation.
The 65 kDa guanylate-binding proteins (GBPs) and the im-
mune-related GTPases (IRGs) are important for immunity
against intracellular pathogens (Figure 2). Although most
studies on GBPs and IRGs have been conducted in mice, rele-
vance of human cognates in bacterial infections are strongly
indicated by their upregulation in blood leukocytes in tubercu-
losis. In fact, GBPs have been consistently characterized as
highly discriminative biomarkers of tuberculosis (Maertzdorf
et al., 2015). GTPase cognates localize to various intracellular
compartments during infection with listeriae and mycobacteria
and contribute to bacterial killing by regulating NADPH activa-
tion, autophagy, or release of antimicrobial peptides (Deretic
et al., 2013). Moreover, phagocytes recruit distinct GBPs to
bacteria-containing vacuoles to initiate defense mechanisms.
Murine GBP2 and GBP5 trigger lysis of phagosomes harboring
salmonellae and direct these pathogens into autophagosomes
(Meunier et al., 2014). These events also promote inflamma-
tion through activation of proinflammatory caspases. So far,
such mechanisms have not been reported for extracellular
bacteria.
Antimicrobial Peptides and Proteins
Antimicrobial peptides (AMPs), which encompass different
chemical classes, are packed in phagocyte granules and due
to their amphipathic nature disturb bacterial membranes leading
to bacteriolysis (Figure 2). Microbicidal activity of defensins has
been shown for L. monocytogenes and M. tuberculosis (Arnett
et al., 2011; Verway et al., 2013). Cathelicidin (LL-37), which is
induced in macrophages and pre-stored in neutrophils, is bac-
tericidal against M. tuberculosis (Sonawane et al., 2011).
P. aeruginosa and S. aureus (Beaumont et al., 2014; Kovach
et al., 2012) can evade AMPs by different mechanisms. Staphy-
lococci secrete aureolysin to inactivate LL-37 and activate
the enzyme MprF to reduce the anionic charge of the cell wall,
thereby limiting binding of cationic AMPs (Thammavongsa
et al., 2015). Phagocytes, particularly neutrophils, possess
endo- and exo-peptidases as well as hydrolases, which facili-
tate cleavage of microbial structures and are mycobactericidal
(Jena et al., 2012). Many bacterial pathogens, including listeriae,
mycobacteria, and staphylococci, evade lysozyme lysis by
peptidoglycan modifications (Davis and Weiser, 2011). Cathep-
sins (Mu¨ller et al., 2014) and matrix metalloproteases (MMP-12)
contribute to direct killing of S. aureus, which secretes protease




Elimination of intracellular pathogens by autophagy, termed xen-
ophagy, can occur in any cell type harboring microbes; however,
it is particularly relevant for phagocytes (Figure 2). The autopha-
gosomes comprise a double layer membrane, in contrast to
phagosomes and phagolysosomes, and can progress to auto-
phagolysosomes by fusion with lysosomes. Genesis of autopha-
golysosomes bypasses interference with endosomal maturation
and thus delivers bacteria to lytic compartments. This defense
mechanism is primarily directed against pathogens occupying
damaged phagosomes or accessing the host cytosol. PRR
cognates (Watson et al., 2015; Deretic et al., 2013), cytokines
(Deretic et al., 2013), andGBPs (Meunier et al., 2014) orchestrate
xenophagy, which contributes to control of M. tuberculosis
(Deretic et al., 2013), L. monocytogenes (Py et al., 2007), and
P. aeruginosa (Yuan et al., 2012). A key role for autophagy in neu-
trophils during tuberculosis has been linked to control of inflam-
mation rather than of bacterial growth (Kimmey et al., 2015).
Althoughmost bacteria adjust to, or protect against, xenophagy,
certain pathogens harness it to their advantage (Figure 3). ActA
hinders xenophagic targeting of listeriae by polymerizing actin
to protect bacteria (Yoshikawa et al., 2009). In contrast, staphy-
lococci promote xenophagy primarily through a-toxin (Mestre
et al., 2010) to ensure their survival. Although xenophagy con-
tributes to host defense against MRSA by inducing disease toler-
ance (Maurer et al., 2015), at the same time it protects S. aureus
against killing within acidified phagosomes (Mestre et al., 2010).
Extracellular Traps
Originally described as a defense mechanism unique to neutro-
phils (Brinkmann et al., 2004), extracellular traps (ETs) have been
identified for other granulocytes and macrophages. NETs are
composed of nuclear chromatin DNA, histones, and granular
proteins, which form an extracellular matrix that kills bacteria
caught in these aggregates (Figure 2). PRR agonists or ROIs
induce NET formation. In vivo, NETs can trap staphylococci
(McDonald et al., 2012). Yet, S. aureus secretes nucleases and
adenosine synthase (Thammavongsa et al., 2015), thereby
resisting their antibacterial effects (Figure 3). Moreover, by
converting DNAwithin NETs to deoxyadenosine, staphylococcal
enzymes initiate caspase-3-dependent macrophage death,
thereby restricting macrophage access within abscesses (Tham-
mavongsa et al., 2013). NETs have been observed in pulmonary
tuberculosis (Repasy et al., 2013; Ong et al., 2015). During
M. tuberculosis infection, IFN-g inducesETsandnecrosis inheavi-
ly infected human macrophages (Wong and Jacobs, 2013). NETs
apparently do not kill mycobacteria; rather, they have immuno-
modulatory functions (Ramos-Kichik et al., 2009). Finally, protec-
tion against NET-mediated killing of P. aeruginosa has been
reported for CF patients (Young et al., 2011).
Degranulation
Upon extravasation to sites of infection, neutrophils perform
exocytosis of their granular content, which can occur indepen-
dently of the DNA release and NET generation. Bacterial stimuli,
such as N-formyl peptides engaging formyl peptide receptor
(FPR) or PRR agonists promote granule exocytosis. Moreover,
integrin-mediated migration, activation of the proline-rich tyro-
sine kinase (Kamen et al., 2011), or ligation of FcRs (Huizingaet al., 1990) induce degranulation and killing of staphylococci
and listeriae (Figure 3). Hly facilitates granule exocytosis, but
its prompt cleavage byMMP-8 explains reduced listerial survival
in neutrophils (Arnett et al., 2014). In tuberculosis, neutrophil
degranulation promotes tissue damage as has been demon-
strated for the AMPK-dependent release of MMP-8, which
facilitates cavitation of granulomas (Ong et al., 2015). Tissue
factors, namely the alveolar lining fluid, modify the cell wall of
M. tuberculosis thereby restricting granule exocytosis upon
bacillary interactions with neutrophils (Scordo et al., 2015),
possibly reducing lung injury.
Inflammation
Phagocytes release cytokines, chemokines, alarmins, and
leukotrienes to fine-tune leukocyte recruitment. They generate
pro-inflammatory (e.g., IL-1, TNF, IL-6, IFN-I) and anti-inflamma-
tory (e.g., IL-10, TGF-b) cytokines as well as lipid mediators
(e.g., PGE2) for autocrine activation. Phagocytes produce pro-
resolving lipid mediators and regulatory cytokines to promote
resolution of inflammation and attainment of anatomical and
functional integrity of infected tissue after pathogen disposal.
The pattern of phagocyte death imprinted by distinct pathogens
also affects inflammation. Successful bacterial pathogens
induce lysis or programed necrosis of the phagocytes (Divangahi
et al., 2013).
Generally, extracellular bacteria developmultiple mechanisms
to hinder or delay leukocyte chemotaxis and employ an array of
toxins to induce cell death. S. aureus provides an instructive
example for bacterial multitasking early during inflammation.
Staphylococci limit leukocyte rolling by binding PSGL-1 through
SSL5 and SSL7 (Langley et al., 2005; Bestebroer et al., 2007),
alter phagocyte adherence to endothelia through adhesins
(Thammavongsa et al., 2015), block complement-dependent
chemotaxis through production of aureolysin and the proteins
CHIPs and SCIN (Jongerius et al., 2007; Thammavongsa et al.,
2015), and cleave CXCR2 via staphopain (Laarman et al.,
2012). Staphylococcal armaments for phagocyte killing are
equally impressive. They employ bicomponent leukotoxins
(e.g., LukA, LukB, and LukE), pore-forming toxins (e.g., hemo-
lysin a [Hla]), and PSMs to induce necrosis. The bicomponent
toxins engage specific leukocyte receptors, such as CCR5
(Alonzo et al., 2013; Spaan et al., 2014), CXCR1, CXCR2
(Reyes-Robles et al., 2013), and CD11b (Mac-1) (DuMont et al.,
2013). Similarly, Hla binds a disintegrin and metalloproteinase
domain-containing protein 10 (ADAM10) on mononuclear cells
(Wilke and Bubeck Wardenburg, 2010), although neutrophils
appear resistant to lysis (Nygaard et al., 2012). The amphipathic
PSMs are inserted in lipid bilayers resulting in neutrophil disrup-
tion. PSMs promote neutrophil recruitment by binding to FPR1
and FPR2 (Thammavongsa et al., 2015) and induce lysis after
phagocytosis of S. aureus (Surewaard et al., 2013). PSMs syner-
gize with Panton-Valentine Lekocidin (PVL) and induce necrop-
tosis in macrophages and neutrophils (Holzinger et al., 2012;
Kitur et al., 2015). Phagocytes generally undergo necrosis
promptly after S. aureus engulfment (Flannagan et al., 2015;
Melehani et al., 2015).
Intracellular bacteria promote phagocyte recruitment and
abundance of locally produced proinflammatory mediators
(e.g., TNF-a, IL-1, IFN I, and IFN II) dictate protective orImmunity 44, March 15, 2016 ª2016 Elsevier Inc. 485
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losis, pulmonary neutrophil dynamics are controlled by CXCR2
cognates primarily released by pneumocytes (Nouailles et al.,
2014; Dorhoi et al., 2013), neutrophilic products such as
S100A proteins (Gopal et al., 2013), and IL-17 and IFN-g from
T lymphocytes (Cruz et al., 2010; Nandi and Behar, 2011).
Recruitment of monocytes is primarily regulated by CCR2 and
CCR5 ligands (Antonelli et al., 2010; Samstein et al., 2013).
Cross-regulation between IL-1 and TNF-a involving pneumo-
cytes and stroma cells (Di Paolo et al., 2015), or phagocyte au-
tocrine regulation through IL-1, IFN-I, and eicosanoids (Mayer-
Barber et al., 2014), or eicosanoids and TNF-a (Tobin et al.,
2010), influence bacterial killing and phagocyte dynamics at
sites of pathology in tuberculosis. Moreover, M. tuberculosis in-
duces soluble mediators to modulate phagocyte death. Tuber-
cle bacilli cause limited macrophage apoptosis during pulmo-
nary disease. Rather, they block this process to promote their
dissemination (Divangahi et al., 2013). At the same time,
M. tuberculosis promotes necrosis (Divangahi et al., 2013), nec-
roptosis (Roca and Ramakrishnan, 2013), and atypical necrosis
(Lee et al., 2011) in macrophages and NETosis in neutrophils
(Ramos-Kichik et al., 2009; Repasy et al., 2013; Ong et al.,
2015). Apoptosis of infected phagocytes promotes T cell immu-
nity and contributes to mycobacterial killing, to some extent (Di-
vangahi et al., 2013). Expectedly, phagocyte lysis facilitates
spread of bacteria and augments pathology.
Upon sensing of bacteria, phagocytes promptly release key
proinflammatory cytokines, including TNF-a and IL-1. Optimal
TLR activation requires degradation of staphylococci in phago-
lysosomes. TLRs and the downstream adaptors MyD88 and
IRAK4 along with NOD2 control TNF-a release during S. aureus
infection (Thammavongsa et al., 2015). Staphylococci employ
SSL3 to prevent TLR-2 stimulation (Yokoyama et al., 2012) and
express aTIRdomain-containing protein, thereby downmodulat-
ing TLR activation (Askarian et al., 2014). Proinflammatory cyto-
kine release downstream of TLR-4 and MyD88 is essential for
clearance of P. aeruginosa (Lovewell et al., 2014). Availability of
TNF-a during tuberculosis is regulated in phagocytes by various
adaptors, including MyD88, caspase recruitment domain-con-
taining protein 9 (CARD9) (Dorhoi and Kaufmann, 2014), and lipid
mediators (Tobin et al., 2010).
The release of IL-1, particularly IL-1b, is governed by infla-
mmasome activation. Numerous bacteria trigger assembly of
multiple inflammasomes. L. monocytogenes activates NLR
family, pyrin domain-containing 3 (NLRP3), absent in melanoma
2 (AIM2), and NLR family CARD domain-containing 4 (NLRC4)
(Williams et al., 2012). P. aeruginosa stimulates the NLRC4 in-
flammasome through its type 3-secretion system (T3SS)
(Miao et al., 2010). Early inflammasome activation worsens
pulmonary infection by exacerbating pathology and limiting
AMP-dependent killing of P. aeruginosa (Faure et al., 2014;
Cohen and Prince, 2013). Staphylococci activate the NLRP3 in-
flammasome through Hla (Kebaier et al., 2012) and PVL (Hol-
zinger et al., 2012; Perret et al., 2012). This is required for cas-
pase-1-dependent inactivation of NADPH and phagosome
acidification (Sokolovska et al., 2013), but also enhances path-
ogenicity of S. aureus (Kebaier et al., 2012). Staphylococcal
leukocidins induce IL-1 release probably by forming pores in
the cell membrane (Melehani et al., 2015). Macrophage-derived486 Immunity 44, March 15, 2016 ª2016 Elsevier Inc.IL-1 stimulates IL-8 release by lung epithelial cells and subse-
quent neutrophil recruitment to restrict infection (Perret et al.,
2012), indicating intense cross-talk between stroma and
phagocytes. M. tuberculosis activates the NLRP3 and the
AIM2 inflammasomes, which appear redundant for generation
of IL-1 during lung infection (Dorhoi and Kaufmann, 2014).
IL-1b, but not IL-1a (Di Paolo et al., 2015), promotes mycobac-
tericidal capacity of macrophages by upregulating TNF-RI
(Jayaraman et al., 2013). Macrophage-derived IL-1 also sti-
mulates AMP synthesis in lung epithelia, which restricts
M. tuberculosis replication (Verway et al., 2013).
Principally, inflammation is terminated, within coordinated
resolution processes (not discussed here), after killing of
invading bacteria. Pathogen persistence can trigger chronic
inflammation resulting in enduring tissue damage. Such immu-
nopathologic alterations, including granulomas and abscesses,
although helpful for bacterial containment, affect architecture
and physiological functions of organs. Staphylococcal ab-
scesses encompass neutrophils, forming layers surrounding
the S. aureus abscess community, and are delimited by a fibri-
nous pseudocapsule. Genesis of such lesions requires homing
of kit+ progenitors to assure continuous local neutrophil supply
(Kim et al., 2011). Within the abscess, staphylococci actively
manipulate immune events to promote their own persistence.
Bacteria mainly affect viability of macrophages within the ab-
scess, thereby blocking macrophage activity (Thammavongsa
et al., 2013). Purulent drainage of lesions favors bacterial
dissemination to surrounding tissue. Tuberculosis granulomas
are highly organized structures with appreciable autonomy.
They are populated by lymphocytes, dendritic cells, diverse
macrophage phenotypes, and irreversibly transformed macro-
phages (Dorhoi and Kaufmann, 2015; Mattila et al., 2013),
such as foamy cells and epithelioid and multinucleated giant
cells. Mycobacterial lipids and host factors (Dorhoi and Kauf-
mann, 2015) trigger genesis of such disease-specific, albeit
non-pathognomonic, end-stage phagocytes. The level of
macrophage activation controls replication of bacilli in granu-
lomas (Mattila et al., 2013) and impacts the extent of lung pa-
thology (Duque-Correa et al., 2014). Although mononuclear
phagocytes influence pathology according to their phenotypic
features, neutrophils in general promote progression toward
caseation and cavitation (Ong et al., 2015; Dorhoi and Kauf-
mann, 2015).
Concluding Remarks
Early on, phagocytes were considered attractive targets for ther-
apy of infectious diseases. Thus, in his 1909 play The Doctor’s
Dilemma, George Bernard Shaw stated ‘‘There is at bottom
only one genuinely scientific treatment for all diseases, and
that is to stimulate the phagocytes’’ (Act 1). Later in the play,
however, inherent risks of phagocyte stimulation were realized
as indicated by the outcry ‘‘Have we overstimulated the phago-
cytes? Have they not only eaten up the bacilli, but attacked and
destroyed the red corpuscles as well?’’ (Act 4). Phagocytes are a
double-edged sword and collateral damage can easily occur by
their activation if not fine-tuned. Host-directed therapy targeting
distinct molecular pathways is increasingly exploited as an
alternative intervention measure to antibiotics in the face of
increasing microbial drug resistance (Zumla et al., 2015). In this
Immunity
Reviewtreatise we emphasized the role of phagocytes in the evolution of
host defense against bacterial pathogens, and in a few cases
discussed resolution after pathogen eradication. Indeed, host-
directed therapy offers options for both eliminating microbes
and remediating tissue damage.ACKNOWLEDGMENTS
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